CGIX Cancer Genetics Inc

Cancer Genetics Inc is an early-stage diagnostics company which develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient.  This company has other shares of common stock that are publicly traded. See the "related symbols" tab.

$4.61
As of 03/30/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/05/2013
Outstanding shares:  7,784,580
Average volume:  1,524,510
Market cap:   $35,886,914
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    13739U203
ISIN:        US13739U2033
Sedol:      BKPJ4D2
Valuation   (See tab for details)
PE ratio:   -8.48
PB ratio:   2.40
PS ratio:   6.24
Return on equity:   -106.43%
Net income %:   -73.65%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy